AJILE- Initial Results Presented Nov02

• 92% procedure success (flow restored, no urgent surgery)

• 16% had ‘AngioJet-only’ for clot treatment

• 66% had lytic infusion ឈhrs; NO major bleeding

• Amputation & mortality rates compared favorably with prior studies

• LOS 5 days, versus 10-14 days in prior studies

Previous slide

Next slide

Back to first slide

View graphic version